Woosok Lee

Woosok Lee

President & Chief Executive Officer

Woosok Lee, the President and CEO of TissueGene, brings a broad and multidisciplinary international experience to the company. In addition to his role at TissueGene, Mr. Lee currently serves as the President and CEO of Kolon Pharmaceuticals, Inc., the President and CEO of Kolon ePlatform, Inc., and the President and CEO of Kolon Life Science, Inc. Mr. Lee received his MBA from the UCLA University in Los Angeles, California, and his Bachelor's degree in Economics from the Seoul National University in Korea.

Bumsup Lee, Ph.D.

Bumsup Lee, Ph.D.

President & Chief Executive Officer

Bumsup Lee, D.V.M., Ph.D., President and CEO of TissueGene, joined TissueGene, Inc. as Chief Operating Officer. He was the Executive Vice President and CTO of Kolon Life Science, Inc (KLS), a position he held from May 2011 to May 2017, where he was responsible for a full range of R&D, clinical, business development, and manufacturing activities. Prior to joining KLS, he worked for biotechs and pharmaceutical companies such as Dong-A pharm, Mitokor, Syrrx, and Takeda San Diego. He has advanced multiple drug candidates through clinical development and won commercialization in the areas of diabetes, arthritis, and cancers. He obtained his D.V.M. and M.S. in pathology from Seoul National University and his Ph.D. from Iowa State University. He was a postdoctoral fellow at the State University of New York.

Soon-Wook Kweon

Soon-Wook Kweon

Chief Financial Officer

Soon-Wook Kweon joined TissueGene, Inc. in May, 2017 as the Chief Financial Officer. Before he joined TissueGene, he served as the Vice President of the Management & Finance Division in Kolon Corporation. He received his Bachelor of Arts in Economics at Korea University in Korea.

Gurdyal Kalsi, M.D.

Gurdyal Kalsi, M.D.

Chief Medical Officer

Dr. Gurdyal Kalsi is TissueGene's Chief Medical Officer and Senior Vice President for Clinical Development & Medical Affairs. Dr. Kalsi directs and oversees clinical development, regulatory and medical affairs functions. Dr. Kalsi most recently served as Corporate Vice President for Clinical Development & Medical Affairs at Emergent BioSolutions Inc. He received his medical degrees in Surgery and Medicine from Glancy Medical School followed by post graduate training in Public Health Medicine at St George's Hospital in London, and Pharmaceutical Medicine specialist training at Cardiff University, UK.

Dr. Kalsi brings a unique perspective to innovative design concepts using surrogate markers. He has a lengthy lifecycle management expertise across advanced technologies addressing human condition unmet needs. He recently received an award from the Maryland Stem Cell Research Fund (TEDCO) to further explore new targets in KOA disease as Principal Investigator.

Moon J. Noh, Ph.D.

Moon J. Noh, Ph.D.

Chief Technology Officer

Dr. Moon J. Noh has been with TissueGene for over 16 years. Prior to his role here, Dr. Noh was the Director of the Biotechnology Lab at Kolon Central Research Park. Dr. Noh holds a Ph.D. and M.S. from the Korea Advanced Institute of Science and Technology in Molecular Biology.